Adsorption of small drug particles at the surface of large excipients

Pharmaceutical Technology Europe

Volumn 18, Issue 1, 2006, Pages 39-44

  Wen, Hong ^a   Qiu, Yong ^b  

^a PFIZER INC   (United States)

^b Impax Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHOIC ACID; 4 NITROANILINE; AEROSIL; ATTAPULGITE; BROMHEXINE; CELLULOSE ACETATE; DIGITOXIN; ETHINYLESTRADIOL; EXCIPIENT; GELUCIRE; GRISEOFULVIN; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INDOMETACIN; KAOLIN; LACTOSE; MACROGOL; MAGNESIUM TRISILICATE; METHYL PARABEN; MICROCRYSTALLINE CELLULOSE; MONTMORILLONITE; ORGANIC SOLVENT; PHENYLBUTAZONE; POTATO STARCH; SALICYLAMIDE; SILICON DIOXIDE; SULFAMETHOXAZOLE; TALC; TANOMASTAT; UNINDEXED DRUG;

ARTICLE; DRUG ADSORPTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG OXIDATION; DRUG POTENCY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG TRANSFORMATION; LOW DRUG DOSE; MOISTURE; PARTICLE SIZE; PH;

EID: 30744457304     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. A. Sallam and N. A. Orr, Expo-Congr. Int. Technol. Pharm. 3rd 3, 28-37 (1983).
2. E.J. De Jong and C.J. De Blaey, Pharmaceutisch Weekblad Scientific Edition 6, 16-17 (1984).
3. E. Yonemochi et al., J. Coll. Interface Sci. 173, 186-191 (1995).
4. H. Takenaka et al., J. Pharm. Sci. 70, 1256-1260 (1981).
5. M.C. Hermosin et al., Pharm. Sci. 70, 189-192 (1981).
6. H. Yuasa et al., Chem. Pharm. Bull. 42, 2327-2331 (1994).
7. K.T. Takaoka and T. M. Kamiichi, USA: Fuji Chemical Industry Co., Ltd., Japan (1996).
8. K. Bechtold-Peters, H. Nguyen and G. Rowley, PCT Int. Appl. Wo: (Boehringer Ingelheim Pharma KG, Germany, 2002).
9. T. Waaler et al., Meddelelser fra Norsk Farmaceutisk Selskap 38, 213-229 (1976).
10. G. T. Greco, Drug Dev. Indust. Pharm. 8, 565-578 (1982).
11. P.C. Schmidt and K. Benke, Drugs Made in Germany 28, 49-55. (1985).
12. L. Mackin et al., Int. J. Pharm. 231, 213-226 (2002).
13. I. Nikolakakis, J.M. Newton and S. Malamataris, Eur. J. Pharm. Sci. 17, 229-238, 2002.
14. U. Barra, F. Lescure and E. Doelker, Pharm. Acta. Helv. 74, 37-42 (1999).
15. Y. Padmadisastra, R A. Kennedy, and P.J. Stewart, Int. J. Pharm. 104, R1-R4, (1994).
16. M.K. Gupta et al., Pharm. Devel. Technol. 6, 563-572 (2001).
17. M.K. Gupta et al., Pharm. Res. 19, 1663-1672 (2002).
18. W.L. Chiou and S. Riegelman, J.Pharm. Sci. 59, 937-942 (1970).
19. N.A. Boraie, S. A. El-Fattah and H.M. Hassan, Pharmazeutische Industrie 48, 1202-1206 (1986).
20. D.C. Monkhouse and J. L. Lach, J. Pharm. Sci. 61, 1430-1435 (1972).
21. D.C. Monkhouse and J.L. Lach, J. Pharm. Sci. 61, 1435-1441 (1972).
22. N.M. Sanghavi et al., Indian Drugs 26, 23-27 (1988).
23. Y. Tozuka, T. Oguchi and K. Yamamoto, Pharm. Res. 20, 926-930 (2003).
24. H. Johansen and N. Moller, J. Pharm. Sci. 67, 134-136 (1978).
25. E. Yonemochi et al., Chem. Pharm. Bull. 37, 3083-3087 (1989).
26. X.S. Pan, Pharmaceutical Sciences: University of Maryland, 15 (2002).
27. Y. Tozuka et al., Bull. Chem. Soc. Jpn. 73, 1567-1572 (2000).
28. B.C. Hancock and G. Zografi, J. Pharm. Sci. 86, 1-12 (1997).
29. Chem. Pharm. Bull. 40, 1257-1260 (1992).
30. M.A. Qtaitat, M.B. Zughul and A.A. Badwan, Drug Dev. Ind. Pharm. 14, 415-429 (1988).
31. J. Verhoeven et al., J. Cont. Rel. 10, 205-217 (1989).